Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | PRTX007 |
| Synonyms | |
| Therapy Description |
PRTX007 is a TLR7 agonist that induces IRF7-mediated interferon signaling and activation of CD8-positive T-cells and NK cells, without inducing a systemic inflammatory response (J Clin Oncol 2026 44: 16_suppl, e14606, Cancer Res 2023;83(8_Suppl):Abstract nr CT180). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| PRTX007 | PRTX-007|PRTX 007 | TLR7 Agonist 16 | PRTX007 is a TLR7 agonist that induces IRF7-mediated interferon signaling and activation of CD8-positive T-cells and NK cells, without inducing a systemic inflammatory response (J Clin Oncol 2026 44: 16_suppl, e14606, Cancer Res 2023;83(8_Suppl):Abstract nr CT180). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|